With the same focus, #SpecializedDiagnostics, Werfen and Omixon are the perfect match. The Omixon team is excited to join Werfen and contribute to #PoweringPatientCare.

Contact us: info@werfen.com | Visit Werfen.com

Omixon | NGS for HLA
  • Products
  • About Us
  • Blog
  • Omixon Academy
  • Resources
  • Contact us
  • Search
  • Request HLA Assay
  • MyOmixon
Welcome to Omixon's blog! We're passionate scientists, software developers and business people, so we like to comment on new developments, our events, announcements or any other scientific topic we think is important. Your comments are welcome too, so connect with us on Social Media!

2015 – A Successful Year in Blogposts

16/12/2015
For Omixon, 2015 was an exciting and successful year with a lot of events, news, travels. We closed the Early Access Program and presented full results at the annual ASHI meeting in Savannah where we held Basic and Advanced workshops on Holotype HLA, and had a fully packed Symposium. We...

 

Read more

News Tagged 2015, APHIA, ASHI, EFI, hla, HLA Twin, holotype hla, News, Omixon, SBRI

Meet Us at the Annual EFI Region 8 EPT Meeting in Bucharest

26/11/2015
Omixon’s CEO, Tim Hague will be presenting a short session, titled Optimizing NGS to Address the HLA Typing Challenge during the Annual EFI Region 8 EPT Meeting in Bucharest, Romania next week.   Date: 5th of December, 2015 Time: 2:00 – 2:15pm EET (Session III, Chairmen: Ingrid Fae, Mehmet Tevfik Dorak) Venue:...

 

Read more

News Tagged EFI, EFI Regional, EPT, hla, meeting, News, ngs

Omixon’s First “Learn Me” Video on the New Features of HLA Twin™

13/11/2015
New Feature Highlights A new release of Omixon HLA Twin is now available. Major re-design has taken place to provide a simplified workspace while adding several new features and improvements. Top New Features in HLA Twin 1.1.2 Modified Dashboard similar to a File Browser enhancing quicker access to the drives, folders and...

 

Read more

News, Training Tagged hla, HLA Twin, learn me, News, Omixon, software

Meet Our New Director of Sales for the Americas

13/11/2015
We are happy to introduce our new colleague, Faisal Mojaddidi, who’s originally from Afghanistan, and based in the US since an early age. Having a background in Psychology and Biology, Faisal is highly passionate about personalized medicine, and he will take care of sales activities as our new Director of Sales...

 

Read more

News Tagged director of sales, News, sales

ASHI 2015, y’all!

15/10/2015
The ASHI event went smashingly for Omixon yet again, with a full soccer-sized team of 11 making the trip from all corners of the US and across the pond from Europe – first to Atlanta, and then by minibus on a road trip to Savannah, Georgia.  In among sweltering humidity...

 

Read more

News Tagged ASHI, hla, HLA Twin, holotype hla, News, Symposium, worksop

Post navigation

← Older posts
Newer posts →

Werfen acquires Omixon

NANOTYPE EU-IVDR

NEW! HOLOGRAFT ONE

Omixon Blog

Werfen acquires Omixon

16/10/2024
Barcelona, Spain May 15, 2024.- Werfen announced today that it has agreed to acquire Omixon, a privately held corporation...

more

SEE MORE »

Events

EVENTS 2024

SEE MORE »

FOLLOW US

TESTIMONIALS

Testimonials

  • The NanoTYPE HLA typing assay is optimally designed and supported by a clear protocol so that the workflow can be easily integrated into any H&I laboratory to be used in daily routine. Dr.Monica Dutescu, MD, PhD, National HLA Laboratory, National Blood Transfusion Institute "Prof.Dr. C.T. Nicolau"
  • “Once again, I congratulate the new version 4.2 of the Twin which is much faster and optimized in processing time and alignment." Romulo Vianna, PhD Rio de Janeiro, State University |UERJ
  • "It's astonishing sometimes how easily HLA Twin deals with challenging samples like rare alleles. The data is there - you're just convinced!" Alexandre Walencik, Biologiste Médical, Laboratoire HLA - Nantes
  • “We are using next-generation sequencing techniques to advance patient care at Almac and we know that accurate data and meaningful data interpretation are dependent upon employing the best analysis tools and techniques. Omixon was also the strongest performer in terms of total mutations detected with a 99.14% detection sensitivity in single-end mode.”Gavin Oliver, Bioinformatics Team Leader at Almac
  • "The Holotype HLA method is optimally designed for the service laboratory user and is supported by a clear and easily followed protocol which facilitates method performance. Omixon is an enabling and supportive company that works with you to deliver successful outcomes for your programme rather than sales."Brendan Clarke, HLA Lab Director at Leeds St. James's University Hospital
  • “Omixon has developed an excellent direct genotyping method from next-generation sequencing that addresses the major problems associated with HLA calling. They have developed industry-leading capabilities that we are very pleased to be able to incorporate into the informatics pipeline that powers our interpretation services offerings.”Wolfgang Daum, CEO of Knome
  • “NGS is rapidly being adopted by clinical and research laboratories worldwide. Easy-to-use analytical methods and software tools that aid the generation of accurate results are critical for the success of this groundbreaking new technology.”Dr. Lajos Pusztai, Professor at the University of Texas MD
    Anderson Cancer Center
  • “Best of all, the HLA types reported were fully concordant with data obtained using SBT.”Mike Tayeb, DNA Genotek
  • "Omixon's Holotype HLA provided greater accuracy with fewer ambiguities, particularly for problematic specimens, than our Sanger SBT procedures."Dr. Pamela Kimball, VCU Health System Authority
  • "The NGS kit for HLA genotyping, unlike others available in the market, provides complete control of the reactions from the beginning to the end of the technical process, thus providing a higher cost-benefit ratio for the Laboratory. HLA TWIN is the best and most complete HLA genotyping program on the market and has helped us solve many problems in our laboratory routine."Dr. Rafael Cita, Fundação Pio XII Barretos
  • "Due to the higher throughput and resolution compared to Sanger sequencing, NGS technology improved significantly HLA typing. Omixon`s Holotype HLA workflow and HLA Twin software could be easily implemented in H&I laboratories. Generation of reliable data and ability to extend the typing to additional loci will allow providing better patient care not only in HSCT but also in organ transplantation."Dr. Milena Ivanova, Bulgarian Bone Marrow Registry

 

Omixon Academy

Improve your knowledge!

Our Training Series provide ABHI accredited webinars, workshops, onsite trainings and online demo.

Read more

 

 

Contact Us

Just ask! Get answers!

Your questions and comments are important to us. We’ve got you covered.

Read more

 

 

Omixon Newsletter

Subscribe now!

By clicking 'Ok' I accept the
Privacy Policy

 

Sitemap

Products

  • NanoTYPE™
  • Holotype HLA™
  • HLA Twin™
  • HoloGRAFT™
  • Training and Field Support

 

Company

  • About
  • Board of Directors
  • Scientific Advisory Board
  • Careers / Internships
  • MyOmixon
  • Cooperations and Sponsorships
  • Events

 

Omixon Academy

  • HLA Twin Videos
  • Lab Train Me Videos
  • Posters
  • Workshops
  • Symposiums
  • Webinars
  • Accreditation

 

Contact us

  • Distributors and Agents

Our Mailing Address:

Omixon Biocomputing Ltd.
H-1117 Budapest,
Kaposvár u. 14-18.,
Hungary, EU

US Branch Office:

Omixon Inc.
6 Liberty Square # 2823
Boston, MA 02109
United States

sales@omixon.com | www.omixon.com

support@omixon.com

 

2012-2022, Omixon Inc. All Rights Reserved.